×
Breaking News
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | Patients May See Improved Outcomes with Ravulizumab
JUST RELEASED | 5th Edition of TIF’s Guidelines for the Management of Transfusion Dependent β-Thalassaemia
TIF AI KNOWLEDGE BOT | Your Go-To Source for Thalassaemia Information
EDUCATIONAL WEBINAR ON HEART COMPLICATIONS IN HAEMOGLOBINOPATHIES | 30 January 2025
HEALTH TECHNOLOGY ASSESSMENT | EU Implements New Rules to Offer Quicker Access to Advanced Medicines
TIF CARE | A New Era in Healthcare Collaboration
TIF READINESS ASSESSMENT TOOL | Is Your Country Ready for Advanced Thalassaemia Therapies?
WEBINAR | New Advances in the Prevention of Thalassaemia: Potential for High-Prevalence Regions
NEW FACTSHEET | The Advanced Therapy Medicinal Products (ATMPs) Labyrinth
POSITION PAPER | The Views of TIF on Advanced Therapy Medicinal Products (ATMPs)
English
العربية
English
Ελληνικά
Français
Deutsch
Italiano
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
TIF Activities
/
22
22
Back to top button
Close
Search for
